Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10988451 MCL-1 inhibitors

Patent 10988451 was granted and assigned to Gilead Sciences on April, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Gilead Sciences

Current Assignee

Gilead Sciences

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

109884510

Patent Inventor Names

Zachary Newby0

Vickie H. Tsui0

William J. Watkins0

Xiaofen Li0

Anna E. Hurtley0

Chandrasekar Venkataramani0

Darryl Kato0

David W. Lin0

...

Date of Patent

April 27, 2021

Patent Application Number

168570210

Date Filed

April 23, 2020

Patent Citations Received

‌

US Patent 11643400 MCL-1 inhibitors

‌

US Patent 11760736 Processes and intermediates for preparing MCL1 inhibitors

‌

US Patent 11325891 Processes and intermediates for preparing MCL1 inhibitors

‌

US Patent 11667652 MCL1 inhibitors

Patent Primary Examiner

‌

Bruck Kifle

Patent abstract

The present disclosure generally relates to compounds and pharmaceutical compositions that may be used in methods of treating cancer.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10988451 MCL-1 inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API